FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
178 listings in the last 30 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Pentoxifylline | Pentoxifylline 400 mg/1 | TabletOral | Advagen Pharma Ltd., | Oct 1, 2026 | 72888-268 |
| Tofacitinib Citrate | Tofacitinib citrate 8.08 mg/1 | Tablet, Film coatedOral | Stellon Biotech Inc. | Oct 1, 2026 | 85972-121 |
| Tofacitinib Citrate | Tofacitinib citrate 16.16 mg/1 | Tablet, Film coatedOral | Stellon Biotech Inc. | Oct 1, 2026 | 85972-122 |
| Selenious acid | Selenious acid 40 ug/mL | Injection, SolutionIntravenous | Resor Labs | Oct 1, 2026 | 87944-001 |
| Pixxoscangadobutrol | Gadobutrol 604.72 mg/mL | Injection, SolutionIntravenous | GE Healthcare Inc. | Sep 30, 2026 | 0407-1066 |
| Maraviroc | Maraviroc 150 mg/1 | Tablet, Film coatedOral | Rhodes Pharmaceuticals LLC | Sep 30, 2026 | 42858-246 |
| Maraviroc | Maraviroc 300 mg/1 | Tablet, Film coatedOral | Rhodes Pharmaceuticals LLC | Sep 30, 2026 | 42858-247 |
| Doxepin Hydrochloride | Doxepin hydrochloride 50 mg/g | CreamTopical | Sun Pharmaceutical Industries, Inc. | Sep 30, 2026 | 51672-1404 |
| Ceftaroline Fosamil | Ceftaroline fosamil 400 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Apotex Corp. | Sep 30, 2026 | 60505-4946 |
| Ceftaroline Fosamil | Ceftaroline fosamil 600 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Apotex Corp. | Sep 30, 2026 | 60505-4947 |
| levocarnitine | Levocarnitine 1 g/5mL | Injection, SolutionIntravenous | Gland Pharma Limited | Sep 30, 2026 | 68083-681 |
| Colesevelam Hydrochloride | Colesevelam hydrochloride 625 mg/1 | Tablet, Film coatedOral | Bionpharma Inc. | Sep 30, 2026 | 69452-582 |
| Exemestane | Exemestane 25 mg/1 | Tablet, CoatedOral | OPKO Pharmaceuticals, LLC | Sep 30, 2026 | 70301-2017 |
| Pantoprazole Sodium | Pantoprazole sodium 40 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | Avenacy, LLC | Sep 30, 2026 | 83634-751 |
| Revtorpykgedatolisib | Gedatolisib 180 mg/1 | Injection, Powder, For solutionIntravenous | Celcuity Inc. | Sep 30, 2026 | 84577-751 |
| Lacosamide | Lacosamide 50 mg/1 | TabletOral | AvPAK | Sep 29, 2026 | 50268-491 |
| Lacosamide | Lacosamide 100 mg/1 | TabletOral | AvPAK | Sep 29, 2026 | 50268-492 |
| Carbamazepine | Carbamazepine 100 mg/1 | Tablet, Extended releaseOral | American Health Packaging | Sep 29, 2026 | 60687-973 |
| Propranolol HCL ER | Propranolol hydrochloride 60 mg/1 | Capsule, Extended releaseOral | Direct_Rx | Sep 29, 2026 | 72189-691 |
| Naproxen | Naproxen 500 mg/1 | TabletOral | Unit Dose Solutions, Inc. | Sep 29, 2026 | 87441-092 |
| Caduetamlodipine and atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | Viatris Specialty LLC | Sep 28, 2026 | 58151-060 |
| Caduetamlodipine and atorvastatin | Amlodipine besylate 10 mg/1; Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | Viatris Specialty LLC | Sep 28, 2026 | 58151-061 |
| Paroxetineparoxetine hydrochloride hemihydrate | Paroxetine hydrochloride 20 mg/1 | Tablet, Film coatedOral | Preferred Pharmaceuticals Inc. | Sep 28, 2026 | 68788-4130 |
| Ascorbic acid | Ascorbic acid 500 mg/mL | InjectionIntravenous | Zydus Pharmaceuticals USA Inc. | Sep 28, 2026 | 70710-2162 |
| Ascorbic acid | Ascorbic acid 500 mg/mL | InjectionIntravenous | Zydus Pharmaceuticals USA Inc. | Sep 28, 2026 | 70710-2163 |